BOT botanix pharmaceuticals ltd

Ann: March 2025 Quarterly Activities Report and Appendix 4C, page-159

  1. WBA
    2,582 Posts.
    lightbulb Created with Sketch. 473
    Appreciate this @BuffetsCleaner. My thoughts only not advice.

    50m monthly revenue at 18 month mark.
    5.5 years patent left at 18 month mark.
    Revenue locked in and continuing to grow.
    Less sales staff required at that point.

    66 months of at least 50m monthly or in excess of 300bn (noting product is best in class presently) and refills continuing.
    Growth to come in other jurisdictions.

    50m x 14 times (noting life of patent payments 300bn)

    Cut the cheque at USD7bn... in next 6 months...AUD weak against USD so why wait
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
29.5¢
Change
0.000(0.00%)
Mkt cap ! $578.4M
Open High Low Value Volume
29.5¢ 30.5¢ 28.3¢ $3.185M 10.93M

Buyers (Bids)

No. Vol. Price($)
6 160165 29.0¢
 

Sellers (Offers)

Price($) Vol. No.
29.5¢ 166 1
View Market Depth
Last trade - 16.10pm 17/06/2025 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.